1. Introduction {#sec1}
===============

Age-related cataracts are the leading causes of blindness among the elderly population, affecting nearly 50% of 180 million visually impaired people in the world \[[@B1]\]. Although the surgery has proved effective for cataracts, it still exists in many risks and complications \[[@B2]\]. It is estimated that if the onset of clinical cataract can be delayed for 10 years, half of the cataract surgeries will not be necessary \[[@B3]\]. Thus, to delay or prevent cataract development would be important both for increasing the well-being of older adults and for reducing medical care costs. Oxidative stress caused by reactive oxygen species (ROS) has long been recognized as the major contributor to the formation of cataract, and hydrogen peroxide (H~2~O~2~) is the main intracellular ROS in the aqueous humor, which can activate multiple signaling events such as the activation of the caspases, the Bcl-2 family, the mitogen-activated protein kinases (MAPKs), and NF-*к*B pathways to induce lens epithelial cell (HLE) apoptosis and cause lens opacification, resulting in subsequent cataract development \[[@B4]--[@B7]\]. Therefore, to protect human lens epithelial cells from oxidative stress-induced apoptosis is an important strategy in preventing and delaying cataract formation.

*p*-Coumaric acid (*p*-CA) is a phenolic acid which is widely distributed in many plants and human diets such as cereals, fruits, and vegetables, possessing versatile medicinal activities including antioxidant, cardioprotective, antimelanogenic, antimutagenic, antiplatelet, anti-inflammatory, and immunomodulatory actions \[[@B8]--[@B13]\]. Previous studies reported that *p*-CA is effective to protect the cornea from UVB-induced oxidation damage *in vivo* and *in vitro* \[[@B14]--[@B16]\]. Other studies also proposed that *p*-CA could prevent cells from oxidative stress-induced apoptosis \[[@B17], [@B18]\]. However, the molecular mechanisms behind its protection against oxidative stress remain unknown. In our preliminary work, we screened the protective effects of natural compounds on H~2~O~2~-induced oxidative damage in human lens epithelial cells and found that *p*-CA exerts a potent protective effect on H~2~O~2~-induced oxidative stress in human lens epithelial cells (SRA 01--04). In the present study, we therefore investigated the effect of *p*-CA on H~2~O~2~-induced apoptosis in human lens epithelial (HLE) cells and its molecular mechanisms involved.

2. Materials and Methods {#sec2}
========================

2.1. General {#sec2.1}
------------

Fetal bovine serum (FBS), 0.25% trypsin, and DMEM/F12 medium were obtained from Gibco (Grand Island, NY, USA). Dimethyl sulfoxide (DMSO), H~2~O~2~, cocktail of protease inhibitors, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Quick start Bradford 1x dye reagent was from Bio-Rad Laboratories Inc. (Berkeley, California, USA). Anti-cleaved caspase-3, anti-cleaved caspase-9, anti-p-p38, anti-p-ERK, anti-p-JNK, anti-β-actin, U0126, LY2228820, and SP600125 were obtained from Cell Signal Technology (Beverly, MA, USA). The ECL detection kit was acquired from Amersham Pharmacia (Arlington Heights, IL, USA). The annexin V/FITC kit was purchased from eBioscience (Bender MedSystems GmbH, Vienna, Austria). T-SOD, CAT, and GSH-Px colorimetric activity assay kits were purchased from Jiancheng Bioengineering Institute (Nanjing, China). H2DCF-DA was obtained from Beyotime (Beyotime Institute of Biotechnology, Shanghai, China).

2.2. Cell Culture {#sec2.2}
-----------------

Human lens epithelial (HLE) cells SRA 01/04 were purchased from the Chinese Academy of Medical Sciences (Beijing, China). The HLE cells were cultured as a monolayer in DMEM/F12 medium supplemented with 15% heat-inactivated FBS, penicillin (100 U/mL), and streptomycin (100 *μ*g/mL) and were maintained under standard cell culture conditions at 37°C in a humidified atmosphere of 5% CO~2~. The cells were routinely subcultured every 2-3 days.

2.3. Cell Viability {#sec2.3}
-------------------

The cells were cultured in 96-well microplates with a density of 1 × 10^4^ cells/well and incubated with different concentrations of *p*-CA (0--100 *μ*M), respectively, with or without the exposure of H~2~O~2~. After 24 h incubation, the culture medium was removed and cell viability was measured using the MTT method as previously described \[[@B19]\].

2.4. Detection of Cell Apoptosis {#sec2.4}
--------------------------------

The percentage of apoptotic cells was assayed using the annexin V/FITC apoptosis detection kit according to the manufacturer\'s directions. Briefly, cells were plated and incubated in 6-well plates at a density of 1 × 10^6^ cells/well. After exposure to H~2~O~2~ (275 *μ*M) and/or indicated concentrations of *p*-CA for 6 h, the cells were harvested by 0.25% trypsin and washed twice with ice-cold PBS. The cell pellets were resuspended in binding buffer (1x) prior to the addition of 5 *μ*L FITC-labeled annexin V and 10 *μ*L propidium iodide (PI) for 15 min at room temperature in the dark. The level of cell apoptosis was immediately analyzed on a flow cytometer (Becton Dickinson, San Jose, CA, USA).

2.5. Reactive Oxygen Species (ROS) Generation Assay {#sec2.5}
---------------------------------------------------

The intracellular ROS levels were evaluated using the ROS-specific fluorescent dye H2DCF-DA. After indicating treatments, cells were washed with PBS for three times and stained with H2DCF-DA, incubated at 37°C for 30 min in the darkness. Furthermore, cells were harvested and the generation of ROS was quantified by measuring the intracellular fluorescence intensity by a flow cytometer. The samples were then analyzed with FlowJo 7.6.1.

2.6. Measurement of Mitochondrial Membrane Potential (Δ*ψ*m) and the Activities of Antioxidant Enzymes {#sec2.6}
------------------------------------------------------------------------------------------------------

The mitochondrial membrane potential was tested using Rhodamine123 (Rh123) as previously described \[[@B20]\]. As well, T-SOD, CAT, and GSH-Px activities were all measured as previously described using a colorimetric assay kit according to the manufacturers\' instructions \[[@B20]\].

2.7. Immunoblotting {#sec2.7}
-------------------

Cells were incubated in 6-well plates at a density of 1 × 10^6^ cells/well. After exposure to H~2~O~2~ (275 *μ*M) and/or indicated concentrations of *p*-CA for 24 h, the cells were washed twice with ice-cold PBS and then lysed using RIPA buffer for 30 min on ice. Protein concentrations were quantified using the BCA protein assay kit \[[@B21]\]. And then, protein from each sample (50 *μ*g) was separated by 12% SDS-PAGE gels and transferred onto nitrocellulose membranes. After incubation with primary antibodies against cleaved caspase-3, cleaved caspase-9, p-p-38, p-ERK, p-JNK, and *β*-actin, followed by incubations with the appropriate secondary antibodies conjugated with HRP as our previously described method \[[@B22]\], the blots were detected by enhanced chemiluminescence (ECL), and then protein bands were quantified by densitometric analysis using Image-Pro Plus® software (Media Cybernetics Inc., USA).

2.8. Statistical Analysis {#sec2.8}
-------------------------

The data are presented as the mean value ± standard error of the mean (SEM). The difference between the mean values was evaluated using one-way ANOVA, followed by Duncan\'s multiple range tests. Comparisons were performed using GraphPad Prism 5.0 software (GraphPad Software Inc., San Diego, CA, USA). A *P* value \< 0.05 was considered statistically significant.

3. Results and Discussion {#sec3}
=========================

It is well-known that the apoptosis of lens epithelial cells plays a vital role in cataract formation, and oxidative stress induced by ROS such as O~2~^−^ and H~2~O~2~ has been recognized as an important mediator to induce apoptosis of lens epithelial cells \[[@B3], [@B5], [@B6]\]. Therefore, in the study, H~2~O~2~ was used to induce oxidative injury of lens epithelial cells. After H~2~O~2~ exposure, the cells showed a high cell apoptosis rate and 275 *μ*M H~2~O~2~ was set as the working concentration ([Figure 1(b)](#fig1){ref-type="fig"}). In parallel, HLE cells were treated with different concentrations of *p-*CA (0, 0.3, 1, 3, 10, 30, and 100 *μ*M) for 24 h and no significant cytotoxicity was observed ([Figure 1(c)](#fig1){ref-type="fig"}). And then, the dose response of *p*-CA was assayed on H~2~O~2~-treated HLE cells, and the result showed that pretreatment with *p*-CA (3--100 *μ*M) significantly prevented H~2~O~2~-induced cell death in a dose-dependent manner ([Figure 1(d)](#fig1){ref-type="fig"}). To quantitatively examine the protective potential of *p*-CA against H~2~O~2~-induced cell death in HLE cells, the percentage of apoptotic cells was detected by the annexin V/PI double staining method. As shown in [Figure 2(a)](#fig2){ref-type="fig"}, the percentage of total apoptotic cells (the sum of early-stage apoptotic cells (annexin V^+^/PI^−^ cells) and late-stage apoptotic cells (annexin V^+^/PI^+^)) was significantly increased after the exposure of 275 *μ*M H~2~O. Compared to the cells treated with H~2~O~2~ alone, pretreatment with *p*-CA (3, 10, and 30 *μ*M) resulted in a significant decrease of apoptotic cells in the total population of cells in a dose-dependent manner. Caspases are the main initiators and executioners of apoptosis \[[@B23], [@B24]\]. As one of the key effectors, caspase-3 is activated through cleavage by caspase-9 and involved in the mitochondria-mediated pathway. We thus examined the expressions of cleaved caspase-3 and cleaved caspase-9 using Western blot. As shown in [Figure 2(b)](#fig2){ref-type="fig"}, the expressions of cleaved caspase-3 and cleaved caspase-9 were markedly upregulated after H~2~O~2~ treatment. In contrast, pretreatment with *p*-CA (3, 10, and 30 *μ*M) significantly inhibited the upregulation of cleaved caspase-3 and cleaved caspase-9. Collectively, these results suggested that *p*-CA exhibits a potent protective effect against H~2~O~2~-induced apoptosis in HLE cells.

Oxidative stress can be defined as the imbalance between prooxidant/antioxidant that can occur as a result of an increase in free radical production and/or a decrease in radical scavenging capability of antioxidant defense systems. We therefore detected the production of intracellular free radical ROS in H~2~O~2~-induced HLE cells, as shown in [Figure 3(a)](#fig3){ref-type="fig"}. When the cells were exposed to H~2~O~2~, the generation of ROS increased significantly, whereas pretreatment with *p*-CA (3, 10, and 30 *μ*M) significantly inhibited H~2~O~2~-induced production of intracellular ROS in a dose-dependent manner. The mitochondria are the major location to produce intracellular ROS, and ROS overload would result in lysosomal leakage through the mitochondrial outer membrane and mitochondrial dysfunction. A significant reduction of mitochondrial membrane potential (Δ*ψ*m) is a symbolic feature of early apoptosis. We further determined the loss of Δ*ψ*m in H~2~O~2~-induced HLE cells. As shown in [Figure 3(b)](#fig3){ref-type="fig"}, exposure of HLE cells to H~2~O~2~ for 6 h could significantly increase the percentage of cells with Δ*ψ*m loss, which is up to 29.0%, and pretreatment with *p*-CA (3, 10, and 30 *μ*M) could significantly reduce the percentage of cells with Δ*ψ*m loss to 23.7%, 21.2%, and 15.8% in a dose-dependent manner. In parallel, we also detected the radical scavenging capability of antioxidant defense systems of HLE cells, such as the activities of T-SOD, GSH-Px, and CAT enzymes. Compared to the untreated control, H~2~O~2~ decreased the activities of T-SOD, CAT, and GSH-Px near 2-fold. In H~2~O~2~-treated HLE cells, pretreatment with *p*-CA (3, 10, and 30 *μ*M) could significantly enhance the activities of T-SOD, CAT, and GSH-Px in dose-dependent manners as shown in [Figure 4](#fig4){ref-type="fig"}. These results indicated that *p*-CA possesses potent antioxidant activities against H~2~O~2~-induced impairment in HLE cells.

To explore the molecular mechanisms involved in the protective effects of *p*-CA against H~2~O~2~-induced apoptosis, we evaluated the possible influence of this compound on the expression of mitogen-activated protein kinases (MAPKs), namely, ERK, JNK, and p38, which play important roles in the regulation of intracellular metabolism and responding to external stress \[[@B6]\]. Several previous investigations reported that *p*-CA reduced the oxidative stress of various cells via the inhibition of the MAPK signaling cascade \[[@B25]--[@B27]\]. Our data showed that ([Figure 5(a)](#fig5){ref-type="fig"}) incubation with H~2~O~2~ led to a massive increase of p-p38, p-ERK, and p-JNK. As expected, increased p-p38, p-JNK, and p-ERK were significantly rescued by *p*-CA in a dose-dependent manner. To further confirm the role of the MAPK signaling pathway to mediate the inhibitory effect of *p*-CA on H~2~O~2~-induced apoptosis in HLE cells, we have detected the cell viability of cells exposed to H~2~O~2~ with the ERK inhibitor (U0126) or p-38 inhibitor (LY2228820) or JNK inhibitor (SP600125), respectively. As shown in [Figure 5(b)](#fig5){ref-type="fig"}, compared to cells treated with *p*-CA alone in the presence of H~2~O~2~, HLE cells treated with *p*-CA combined with LY2228820 or U0126 or SP600125 in the exposure of H~2~O~2~ exhibited a much higher cell viability, which displayed the protective effect of *p*-CA on H~2~O~2~-induced apoptosis in HLE cells via affecting MAPK signaling pathways.

4. Conclusion {#sec4}
=============

In conclusion, the data from this study demonstrate that *p*-CA, a natural compound, could protect HLE cells from oxidative stress-induced apoptosis through modulating MAPK signaling pathways. Our findings suggest a potential use of *p*-CA in the prevention of cataractogenesis.
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![Effects of *p*-CA on cell viability of H~2~O~2~-induced cell death in HLE cells. (a) Structure of *p*-CA. (b) HLE cells were treated with a series of H~2~O~2~ concentrations (0--300 *μ*M) for 24 h. (c) HLE cells were incubated with different concentrations of *p*-CA (0--100 *μ*M) for 24 h. (d) HLE cells are preincubated with *p*-CA (0--100 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treated for 24 h. Cell viability was measured using the MTT method. Data are expressed as the mean ± SEM (*n* = 3). ^\#\#\#^*P* \< 0.001, compared with the untreated control group; ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 and ^∗∗∗^*P* \< 0.001, compared with the H~2~O~2~-treated group.](OMCL2018-8549052.001){#fig1}

![*p*-CA prevented H~2~O~2~-induced cell apoptosis in HLE cells. (a) HLE cells were pretreated with *p*-CA (3, 10, and 30 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treatment for 6 h. The apoptotic cells were detected by flow cytometry after staining with both FITC annexin V and PI. (b) HLE cells were pretreated with *p*-CA (3, 10, and 30 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treatment for 24 h. Cleaved caspase-3 and cleaved caspase-9 expressions were measured by Western blot. Data are expressed as the mean ± SEM (*n* = 3). ^\#\#\#^*P* \< 0.001, compared with the untreated control group; ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, and ^∗∗∗^*P* \< 0.001, compared with the H~2~O~2~-treated group.](OMCL2018-8549052.002){#fig2}

![*p*-CA suppressed intracellular ROS production and mitochondrial membrane potential loss in H~2~O~2~-treated HLE cells. (a) HLE cells were pretreated with *p*-CA (3, 10, and 30 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treatment for 6 h. After staining with H2DCF-DA, cells were incubated at 37°C for 30 min in the darkness and then detected by flow cytometry. (b) HLE cells were preincubated with *p*-CA (3, 10, and 30 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treatment for 6 h. Cells were incubated with Rh123 for 30 min at 37°C, and then the fluorescent intensity was analyzed using flow cytometry. Data are expressed as the mean ± SEM (*n* = 3). ^\#\#\#^*P* \< 0.001, compared with the untreated control group; ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, and ^∗∗∗^*P* \< 0.001, compared with the H~2~O~2~-treated group.](OMCL2018-8549052.003){#fig3}

![*p*-CA enhanced the activities of T-SOD, CAT, and GSH-Px in H~2~O~2~-treated HLE cells. HLE cells were pretreated on *p*-CA (3, 10, and 30 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treatment for 24 h. The activities of T-SOD (a), CAT (b), and GSH-Px (c) were measured by commercial assay kits. Data were expressed as the mean ± SEM (*n* = 3). ^\#\#\#^*P* \< 0.001, compared with the untreated control group; ^∗^*P* \< 0.05 and ^∗∗^*p* \< 0.01, compared with the H~2~O~2~-treated group.](OMCL2018-8549052.004){#fig4}

![*p*-CA suppressed MAPK signals in H~2~O~2~-treated HLE cells. (a) HLE cells were pretreated on *p*-CA (3, 10, and 30 *μ*M) for 2 h before 275 *μ*M H~2~O~2~ treatment for 24 h. Cells were lysed, and then p-p-38, p-ERK, and p-JNK expressions were measured using Western blot. (b) HLE cells were pretreated on *p*-CA (10 *μ*M) or ERK inhibitor (FR180204, 1.25 *μ*M) or p-38 inhibitor (PD169316, 1.25 *μ*M) or JNK inhibitor (SP600125, 1.25 *μ*M) or a combination of both *p*-CA and SP600125 or PD169316 and FR180204 for 2 h before 275 *μ*M H~2~O~2~ treatment for 24 h; then the cell viability was measured using the MTT method. Data are expressed as the mean ± SEM (*n* = 3). ^\#\#\#^*P* \< 0.001, compared with the untreated control group; ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 and ^∗∗∗^*P* \< 0.001, compared with the H~2~O~2~-treated group; and ^\$^*P* \< 0.05, compared with the H~2~O~2~ + *p*-CA group using Student\'s *t*-test.](OMCL2018-8549052.005){#fig5}
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